Description

10-Bromo-6-[(6,11-Dihydro-6,11-Dioxo-2-Phenylnaphtho[2,3-G]Quinazolin-4-Yl)Amino]Naphth[2,3-C]Acridine-5,8,14(13H)-Trione is a sophisticated, high-purity organic compound designed for advanced research and development applications. This complex heterocyclic molecule serves as a critical building block and functional intermediate in the synthesis of novel materials and active pharmaceutical ingredients (APIs). It is essential for researchers and manufacturers in the pharmaceutical, agrochemical, and specialty chemical sectors who require precise, high-quality intermediates for cutting-edge product development.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel therapeutic agents, particularly in oncology and antiviral research.
• Organic Light-Emitting Diode (OLED) Research: Used in the development of advanced electron-transport or emissive layer materials due to its complex conjugated structure.
• Dye and Pigment Synthesis: Serves as a core structure for creating high-performance, specialized dyes and pigments with specific light-absorption properties.
• Agrochemical Development: Employed as an intermediate in the research and synthesis of new, targeted crop protection agents.
• Academic & Industrial R&D: A valuable tool for chemists exploring novel heterocyclic chemistry, photophysical properties, and structure-activity relationships.
• Material Science: Investigated for potential use in organic semiconductors and other advanced functional materials.

Basic Information

Product Name	10-Bromo-6-[(6,11-Dihydro-6,11-Dioxo-2-Phenylnaphtho[2,3-G]Quinazolin-4-Yl)Amino]Naphth[2,3-C]Acridine-5,8,14(13H)-Trione
CAS No.	83732-88-1
Molecular Formula	C43H21BrN4O5
Molecular Weight	753.56 g/mol
Synonyms	10-Bromo-6-[(6,11-dihydro-6,11-dioxo-2-phenylnaphtho[2,3-g]quinazolin-4-yl)amino]naphth[2,3-c]acridine-5,8,14(13H)-trione; Naphth[2,3-c]acridine-5,8,14(13H)-trione, 10-bromo-6-[(6,11-dihydro-6,11-dioxo-2-phenylnaphtho[2,3-g]quinazolin-4-yl)amino]-; 10-Bromo-6-[(6,11-dioxo-2-phenyl-6,11-dihydro-naphtho[2,3-g]quinazolin-4-yl)amino]-13H-naphth[2,3-c]acridine-5,8,14-trione; 83732-88-1; BRD-K4477; BDBM50382857; STK562159; ZINC000003869756
EINECS	Contact for details

Quality Control

Our 10-Bromo-6-[(6,11-Dihydro-6,11-Dioxo-2-Phenylnaphtho[2,3-G]Quinazolin-4-Yl)Amino]Naphth[2,3-C]Acridine-5,8,14(13H)-Trione is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to cGMP principles where applicable to support our clients' regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	Orange to red-brown powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Loss on Drying	≤ 2.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 5.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.